No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.

Abstract

OBJECTIVES Data from a vaccine trial and from post-vaccine surveillance in the United Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection against HPV-6/11 and protection against anogenital warts (AGW). We studied the effect of the bivalent vaccine on genital HPV-6/11 positivity and AGW in the Netherlands. METHODS We included… (More)
DOI: 10.1016/j.jinf.2017.01.007

Topics

Cite this paper

@article{Woestenberg2017NoEF, title={No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.}, author={Petra J. Woestenberg and Audrey J. King and Marianne A. B. van der Sande and Robine Donken and Suzan Leussink and Fiona van der Klis and Christian J. P. A. Hoebe and Johannes Antonie Bogaards and Birgit H. B. van Benthem}, journal={The Journal of infection}, year={2017}, volume={74 4}, pages={393-400} }